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Experimental procedures

Synthesis of tert-butyl 2-(2-(2-(methylthio)ethyl)-4-oxoquinazolin-1(4H)-yl)acetate (6)
To a solution of 2-aminobenzamide (301 mg, 2.21 mmol) in DMF (4.0 mL), were added K 2 CO 3 (919 mg, 6.65 mmol) and tert-butyl bromoacetate (485 µL, 3.31 mmol) and stirred at 90 o C. After stirred for 40 h, the mixture was cooled to room temperature and diluted with CH 2 Cl 2 (30 mL) and water (10 mL). The organic layer was separated, dried over anhydrous Na 2 SO 4 , filtered, and evaporated under reduced pressure. The residue was purified by column chromatography (CHCl 3 / MeOH = 99/ 1) to give the compound 5 (265.7 mg, 48%) as a pale yellow solid. To a solution of 5 (100.3 mg, 0.40 mmol) in CH 2 Cl 2 (3.5 mL), was added 3-(methylthio)propionyl chloride (140 µL, 1.21 mmol) and stirred at room temperature. After stirred for 3 h, the reaction mixture was diluted with CH 2 Cl 2 (10 mL), and washed with saturated aqueous NaHCO 3 (15 mL × 4), water (15 mL) and brine (15 mL). The organic layer was dried over anhydrous Na 2 SO 4 , filtered, and concentrated reduced pressure. The crude was suspended in Et 2 O/ hexane = 1/ 2 (10 mL), and the solid was filtered off, followed by washing with Et 2 O/ hexane = 1/ 2 (20 mL) to afford the desired product 6 (97.1 mg, 73%) as a pale yellow solid. 1 
Synthesis of 2-(2-(2-(methylthio)ethyl)-4-oxoquinazolin-1 (4H)-yl)acetic acid (7)
To a solution of compound 6 (41 mg, 0.13 mmol) in DCM (0.2 mL), were added triisopropyl silane (40 µL, 0.19 mmol) and TFA (0.82 mL), then the reaction mixture was stirred at room temperature. After stirred for 4 h, the reaction mixture was then concentrated under reduced pressure and coevaporated with acetonitrile three times. The residue was purified by column chromatography (EtOAc only → EtOAc: MeOH = 4: 1) to afford compound 7 as a white solid (25 mg, 72%). Synthesis of tert-butyl(2-(2-(2-(acridin-9-ylamino)ethoxy)ethoxy) ethyl) carbamate (10)
S3
The compound 9-chloroacridine (8) (230 mg, 1.08 mmol) and amine linker (9) (321 mg, 1.29 mmol) were dissolved in phenol (1.1 g) then the reaction mixture was stirred at 100 o C for 3h. The reaction mixture was cooled down to room temperature and was poured 1 N aqueous NaOH (10 mL). The solution was extracted with CH 2 Cl 2 (30 mL × 2), washed with brine (20 mL) and dried over anhydrous Na 2 SO 4 , filtered and evaporated. The residue was purified by column chromatography (CHCl 3 : MeOH = 9: 1 → 7: 1 → 5: 1 → 3: 1) to afford compound 10 as a yellow oil (442 mg, 96%). 1 To a solution of compound 10 (14 mg, 0.03 mmol) in DCM (0.2 mL) was added TFA (0.95 mL) then the reaction mixture was stirred at room temperature for 2h. The reaction mixture was then concentrated and co-evaporated with acetonitrile three times. The residue was passed through amino silica, concentrated, and then dissolved in DMF (0.5 mL). The reaction solution was added to a new flask having compound 7 (11 mg, 0.04 mmol) in DMF (0.1 mL). To the reaction mixture were added HBTU (15 mg, 0.04 mmol), HOBt (5.3 mg, 0.04 mmol), DIPEA (58 µL, 0.33 mmol) and the reaction mixture was stirred at room temperature. After stirred for 2 h, the reaction mixture was diluted with DCM, and then washed with sat. aq. NaHCO 3 and brine. The organic layer was separated and dried over Na 2 SO 4 , filtered, and evaporated. The residue was purified by column chromatography (EtOAc : MeOH = 49:1 → 29:1 → 19:1 → 9:1) to afford compound 3-SMe as a yellow solid (10 mg, 52%). A part of this solid was further purified by reverse phased HPLC with C-18 column (Nacalai tesque: COSMOSIL 5C 18 -AR-II, 10×250 mm) by a liner gradient of 0-45%/30min acetonitrile in 0.1% TFA buffer at a flow rate of 4 mL/min at 40 o C, and monitored by UV detection at λ = 254 nm and fluorescence detection (λ ex = 266 nm, λ em = 450 nm), to afford the desired product as a pale yellow solid. The concentration of 3-SMe was determined by quantitative 1 H-NMR using maleic acid as an internal standard (ε 260 = 48,750 M -1 ･cm -1 ). 
Synthesis of aminoacridine-VQ conjugate methylsulfoxide precursor (3-S(O)Me)
To a solution of 3-SMe (5 nmol) in DMSO (0.5 µL) was added a solution of MMPP (5 nmol) in water (9.5 µL) and the mixture was rest at room temperature for 1 min to afford compound 3-S(O)Me. The precursor was used for alkylation reactions without further purification. For ESI-MS and NMR measurements, the 3-S(O)Me was purified by reverse phased HPLC with C-18 column (Nacalai tesque: COSMOSIL 5C 18 
Synthesis of aminoacridine-VQ conjugate thiophenol (3-SPh) precursors
To a solution of 3-SMe (2 nmol) in DMSO (2 µL) was added a solution of MMPP (1.2 nmol) in water (1.2 µL) and the mixture was rest at room temperature for 1 min to afford compound 3-S(O)Me. Carbonate buffer pH 10 (50 mM, 0.4 µL) and thiophenol (100 nmol) in DMSO (0.2 µL), and DMSO (1.2 µL) were then added and the mixture was incubated at 37°C for 3 h. The solution was purified by HPLC to afford compound 3-SPh. Large scale synthesis: To a solution of 3-SMe (11.8 µmol) in DMSO (250 µL) and H 2 O (930 µL) was added a solution of MMPP (10.8 µmol) in water (708 µL) and the mixture was rest at room temperature for 1 min to afford compound 3-S(O)Me. Carbonate buffer pH 10 (50 mM, 232 µL), thiophenol (5.9 mmol) in DMSO (116 µL), and DMSO (690 µL) were then added and the mixture was incubated at 37°C for 3 h. To the solution was added 2-2'-dipyridyldisulfide (2.9 mmol) in DMSO (58 µL) then the solution was purified by HPLC to afford compound 3-SPh. 1 
Synthesis of aminoacridine-VQ conjugate phenylsulfoxide precursor (3-S(O)Ph)
To a solution of 3-SPh (5 nmol) in DMSO (0.5 µL) was added a solution of MMPP (5 nmol) in water (9.5 µL) and the mixture was rest at room temperature for 1 min to afford compound 3-S(O)Ph. The precursor was used for alkylation reactions without further purification.
General procedure of synthesis of aminoacridine-VQ conjugate 4-methoxythiophenol precursor (3-SPhX)
To a solution of 3-SMe (2 nmol) in H 2 O (2 µL) was added a solution of MMPP (1.2 nmol) in water (1.2 µL) and the mixture was rest at room temperature for 1 min. Carbonate buffer pH 10 (50 mM, 0.4 µL), thiophenol derivatives (100 nmol) in DMSO (0.2 µL), and DMSO (1.2 µL) were then added and the mixture was incubated at 37°C or 45°C (Table S1 ). The solution was purified by HPLC to afford compound 3-SPhX.
Annealing procedure DNA and/or RNA (50 µM) were diluted in these following 1x buffers (50 µL). K + buffer: 100 mM KCl, 10 mM K 2 HPO 4 /KH 2 PO 4 (pH 7.0), 1 mM K 2 EDTA. Na + buffer: 100 mM NaCl, 10 mM Na 2 HPO 4 /NaH 2 PO 4 (pH 7.0), 1 mM Na 2 EDTA. MES buffer: 100 mM NaCl, 50 mM MES (pH 7.0). 
CD measurements
A solution (100 μL) of G4-DNA (2.5 μM) and 3-SMe (0, 2.5, 12.5 or 50 μM) in 1× K + or Na + buffer (containing 2% DMSO, pH 7.0) were transferred to a cylindrical micro cell with a 1-cm path length. Figure S2 . Screening of the leaving group for alkylation. The precursor ligand (50 μM) was incubated with Gquadruplex (G-4) (2.5 μM), duplex (ds) (2.5 μM), and single-stranded (ss) (2.5 μM) DNA at 37 o C in buffer solution. G-4 potassium buffer (K + ): 100 mM KCl, 10 mM K 2 HPO 4 /KH 2 PO 4 (pH 7.0), 1 mM K 2 EDTA, G-4 sodium buffer (Na + ): 100 mM NaCl, 10 mM Na 2 HPO 4 /NaH 2 PO 4 (pH 7.0), 1 mM Na 2 EDTA, ds and ss buffer: G-4 sodium buffer. Table S1 . Synthesis of VQ-SPhX precursors and ESI-HRMS measurements. Figure S8 . Alkylation reaction of G-4 with VQ-SPhX. The precursor ligand (50 μM) was incubated with Gquadruplex (G-4) DNA folded in K + or Na + (2.5 μM) at 37 o C in buffer solution. G-4 potassium buffer (K + ): 100 mM KCl, 10 mM K 2 HPO 4 /KH 2 PO 4 (pH 7.0), 1 mM K 2 EDTA; G-4 sodium buffer (Na + ): 100 mM NaCl, 10 mM Na 2 HPO 4 /NaH 2 PO 4 (pH 7.0), 1 mM Na 2 EDTA. (A) Denaturing gel electrophoresis of the alkylation products for G-4 in K + buffer. Lane 0 is the control G-4 DNA without ligand. (B) Denaturing gel electrophoresis of the alkylation products for G-4 in Na + buffer. The electrophoresis was performed on a 16% denaturing polyacrylamide gel with 20% formamide. 
